Cargando…

Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway

OBJECTIVE: Finding miR-339-5p inhibitory functions in glioma through PTP4A1/HMGB1 pathway. METHODS: From May 2020 to August 2021, 20 glioblastoma and para cancer tissues were chosen for qRT-PCR analysis. The miR-NC, miR-con, miR-339-5PMIMIC, and miR-con + groups were transfected into human glioma U2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Buyi, Wang, Shouyi, Shen, Huanan, Lin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307383/
https://www.ncbi.nlm.nih.gov/pubmed/35872698
http://dx.doi.org/10.1155/2022/2231195
_version_ 1784752750201929728
author Zheng, Buyi
Wang, Shouyi
Shen, Huanan
Lin, Jie
author_facet Zheng, Buyi
Wang, Shouyi
Shen, Huanan
Lin, Jie
author_sort Zheng, Buyi
collection PubMed
description OBJECTIVE: Finding miR-339-5p inhibitory functions in glioma through PTP4A1/HMGB1 pathway. METHODS: From May 2020 to August 2021, 20 glioblastoma and para cancer tissues were chosen for qRT-PCR analysis. The miR-NC, miR-con, miR-339-5PMIMIC, and miR-con + groups were transfected into human glioma U251 cells. The capacity of cell vascular-like structure construction was found by simulating angiogenesis, and the ability of cell movement was examined by cell scratching. The twofold luciferase reporter gene method determined that miR-339-5p targets PTP4A1, and the protein expression levels of PTP4A1 and HMGB1 were examined using Western blot. RESULTS: MiR-339-5P expression was substantially lower in cancer samples than noncancer samples (P < 0.05). PTP4A1 expression in cancer samples was higher than in healthy controls (P < 0.05). The miR-339-5p group produced significantly less vascular-like structures than the NC and miR-con groups (P < 0.05). The miR-339-5p group lowered the invasive index and migratory rate of U251 cells (P < 0.05). PTP4A1 inhibited the luciferase activity of the pTP4A1-WT reporter gene (P < 0.05) but not the PTP4A1-MUT (P > 0.05). The miR-339-5p group had lower protein levels of PTP4A1 and HMGB1 than the NC and miR-con groups (P < 0.05). The development of vascular-like structures was substantially more significant in the miR-con +PTP4A1 group than in the miR-con and miR-339-5p +PTP4A1 groups (P < 0.05). In terms of migration and invasion index, there was a substantial difference between the miR-339-5p +PTP4A1 and the miR-con +PTP4A1 groups (P < 0.05). The miR-con +PTP4A1 group had a greater migration rate and invasive index than the miR-con and miR-339-5p +PTP4A1 groups (P < 0.05). CONCLUSION: MiR-339-5P inhibits angiogenic mimicry, migration, and invasion of brain glioma U251 cells by inhibiting the PTP4A1/HMGB1 signal pathway.
format Online
Article
Text
id pubmed-9307383
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93073832022-07-23 Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway Zheng, Buyi Wang, Shouyi Shen, Huanan Lin, Jie Dis Markers Research Article OBJECTIVE: Finding miR-339-5p inhibitory functions in glioma through PTP4A1/HMGB1 pathway. METHODS: From May 2020 to August 2021, 20 glioblastoma and para cancer tissues were chosen for qRT-PCR analysis. The miR-NC, miR-con, miR-339-5PMIMIC, and miR-con + groups were transfected into human glioma U251 cells. The capacity of cell vascular-like structure construction was found by simulating angiogenesis, and the ability of cell movement was examined by cell scratching. The twofold luciferase reporter gene method determined that miR-339-5p targets PTP4A1, and the protein expression levels of PTP4A1 and HMGB1 were examined using Western blot. RESULTS: MiR-339-5P expression was substantially lower in cancer samples than noncancer samples (P < 0.05). PTP4A1 expression in cancer samples was higher than in healthy controls (P < 0.05). The miR-339-5p group produced significantly less vascular-like structures than the NC and miR-con groups (P < 0.05). The miR-339-5p group lowered the invasive index and migratory rate of U251 cells (P < 0.05). PTP4A1 inhibited the luciferase activity of the pTP4A1-WT reporter gene (P < 0.05) but not the PTP4A1-MUT (P > 0.05). The miR-339-5p group had lower protein levels of PTP4A1 and HMGB1 than the NC and miR-con groups (P < 0.05). The development of vascular-like structures was substantially more significant in the miR-con +PTP4A1 group than in the miR-con and miR-339-5p +PTP4A1 groups (P < 0.05). In terms of migration and invasion index, there was a substantial difference between the miR-339-5p +PTP4A1 and the miR-con +PTP4A1 groups (P < 0.05). The miR-con +PTP4A1 group had a greater migration rate and invasive index than the miR-con and miR-339-5p +PTP4A1 groups (P < 0.05). CONCLUSION: MiR-339-5P inhibits angiogenic mimicry, migration, and invasion of brain glioma U251 cells by inhibiting the PTP4A1/HMGB1 signal pathway. Hindawi 2022-07-15 /pmc/articles/PMC9307383/ /pubmed/35872698 http://dx.doi.org/10.1155/2022/2231195 Text en Copyright © 2022 Buyi Zheng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zheng, Buyi
Wang, Shouyi
Shen, Huanan
Lin, Jie
Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway
title Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway
title_full Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway
title_fullStr Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway
title_full_unstemmed Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway
title_short Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway
title_sort inhibitory effect of mir-339-5p on glioma through ptp4a1/hmgb1 pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307383/
https://www.ncbi.nlm.nih.gov/pubmed/35872698
http://dx.doi.org/10.1155/2022/2231195
work_keys_str_mv AT zhengbuyi inhibitoryeffectofmir3395pongliomathroughptp4a1hmgb1pathway
AT wangshouyi inhibitoryeffectofmir3395pongliomathroughptp4a1hmgb1pathway
AT shenhuanan inhibitoryeffectofmir3395pongliomathroughptp4a1hmgb1pathway
AT linjie inhibitoryeffectofmir3395pongliomathroughptp4a1hmgb1pathway